Development of anti-GD2 Antibody-producing Mesenchymal Stem Cells as Cellular Immunotherapy. Iguchi M, Yagyu S, Kambe K, Higashi M, et al. Anticancer Res 2023;43:2417-2424.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Iguchi M, Yagyu S, Kambe K, Higashi M, et al. Development of anti-GD2 Antibody-producing Mesenchymal Stem Cells as Cellular Immunotherapy. Anticancer Res 2023;43:2417-2424.
PMID: 37247922